Save time and jump to the most important pieces.
Date | Price Target | Rating | Analyst |
---|---|---|---|
2/24/2025 | $5.00 | Buy | Maxim Group |
VSee Health, Inc. (NASDAQ:VSEE), a leader in digital health solutions, customized virtual health workflow integration, and real-time health data analytics, announces the launch of Project MAMA (Mom's AI for Maternity Aid), an innovative telehealth initiative to reduce high maternal mortality rates in rural, isolated Philippines communities of Zamboanga Sibugay. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250516245654/en/Local clinic staff performs a prenatal checkup using the VSee telemedicine kit and digital health platform. Working with maternal care physicians and specialists from Stanford University and Ateneo de Zamboanga
VSee Health, Inc. (the "Company") (NASDAQ:VSEE), announced today that on April 25, 2025, the Company received a notice from The Nasdaq Stock Market LLC ("Nasdaq") stating that because the Company had not yet filed its Annual Report on Form 10-K for the year ended December 31, 2024 (the "Form 10-K"), the Company is not in compliance with Nasdaq's listing rule 5250(c)(1), which requires timely filing of periodic financial reports with the Securities and Exchange Commission (the "SEC"). The Nasdaq notice has no immediate effect on the listing or trading of the Company's common stock or its public warrants on The Nasdaq Capital Market. According to the notice, the Company has 60 calendar days
Strategic Hospital Pilots and Research Partnerships Position Company for Scalable Growth in $787B Digital Health Market VSee Health, Inc. (NASDAQ:VSEE), a rapidly growing leader in AI-powered telehealth, redefining the $787 billion digital healthcare market with its modular, no-code/low-code platform, has completed development of its Telenursing Robotics solution—an AI-driven platform designed to automate routine nursing tasks and reduce labor costs. With nursing expenses representing approximately 60% of hospital operating budgets, this innovation directly targets one of the most pressing cost challenges in healthcare. Initial modeling suggests hospitals deploying VSee's solution could re
8-K - VSEE HEALTH, INC. (0001864531) (Filer)
NT 10-K - VSEE HEALTH, INC. (0001864531) (Filer)
8-K - VSEE HEALTH, INC. (0001864531) (Filer)
Maxim Group initiated coverage of VSee Lab with a rating of Buy and set a new price target of $5.00
4 - VSEE HEALTH, INC. (0001864531) (Issuer)
4 - VSEE HEALTH, INC. (0001864531) (Issuer)
4 - VSEE HEALTH, INC. (0001864531) (Issuer)
SC 13G/A - VSEE HEALTH, INC. (0001864531) (Subject)
SC 13G/A - VSEE HEALTH, INC. (0001864531) (Subject)
SC 13G - VSEE HEALTH, INC. (0001864531) (Subject)
ORLANDO, FL / ACCESSWIRE / December 20, 2024 / RedChip Companies will air an interview with VSee Health, Inc. (NASDAQ:VSEE) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, this Saturday, December 21, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S.Access the interview in its entirety at: https://www.redchip.com/assets/access/vsee_accessIn an exclusive interview, Milton Chen, PhD, co-CEO of VSee Health, appears on the RedChip Small Stocks Big Money™ show on Bloomberg TV to share insight into how VSee Health's differentiated solutions position the company as a growing leader in the $787 billion telehealth
ORLANDO, FL / ACCESSWIRE / December 2, 2024 / RedChip Companies aired interviews with VSee Health, Inc. (NASDAQ:VSEE) and 60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV on November 30. Bloomberg TV is available in an estimated 73 million homes across the U.S.Access the interviews in their entirety at:VSEE: https://www.redchip.com/assets/access/vsee_accessSXTP: https://www.redchip.com/assets/access/sxtp_accessIn an exclusive interview, Imo Aisiku, M.D., co-CEO and Chairman of VSee Health, appears on the RedChip Small Stocks Big Money™ show on Bloomberg TV to share insight into how VSee Health's differentiated so